(rel) -MK 287
(rel) -MK 287 ((rel) -L-680573) is a relative configuration of MK 287. MK 287 is a potent, selective and orally active antagonist of platelet-activating factor receptor (PAFR) . MK 287 can inhibit [3H]C18-PAF binding to human platelet, polymorphonuclear leukocyte (PMN) and lung membranes with K1 values of 6.1, 3.2, and 5.49 nM, respectively. MK 287 can inhibit PAF-induced aggregation of platelets in plasma or gel-filtered platelets and elastase release from PMNs with ED50 values of 56, 1.5 and 4.4 nM. MK 287 can be used for the research of cardiovascular disease, such as thrombosis[1].
Product Specifications
CAS Number
143445-03-8
Product Name Alternative
(rel) -L-680573
UNSPSC
12352005
Target
Platelet-activating Factor Receptor (PAFR)
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neuromodulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/rel-mk-287.html
Smiles
O=S(CCO)(C1=CC([C@H]2O[C@@H](CC2)C3=CC(OC)=C(C(OC)=C3)OC)=CC(OC)=C1OCCC)=O
Molecular Formula
C25H34O9S
Molecular Weight
510.60
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD74 (B-Cell Marker) (CLIP/3127R), CF640R conjugate, 0.1mg/mL
Golgi Complex (AE-6), CF488A conjugate, 0.1mg/mL
